Why the study?
Intradialytic hypotension affects cardiovascular function reflected in autonomic nervous system activity, motivating indirect autonomic assessment via heart rate variability.
Does time-frequency analysis of heart rate variability differentiate between hypotensive and non-hypotensive end-stage renal disease patients during hemodialysis?
Does time-frequency analysis of heart rate variability differentiate between hypotensive and non-hypotensive end-stage renal disease patients during hemodialysis?
Time-frequency analysis of heart rate variability can identify autonomic nervous system decompensation and discriminate between hypotensive and non-hypotensive patients during hemodialysis.
Answers are grounded in this paper and cite their sources.
May differentiate autonomic responses during hemodialysis; hypothesis-generating and requires prospective validation before clinical use.
Intradialytic hypotension occurs in 10–30% of hemodialysis (HD) sessions. This phenomenon affects the cardiovascular system’s functions, which are reflected in the activity of the autonomic nervous system (ANS). To indirectly assess the ANS during HD, we analyzed the mean R–R intervals and the spectral power of heart rate variability (HRV) from 20 end-stage renal disease patients divided into hypotensive and non-hypotensive groups. The spectrotemporal analysis was accomplished using short-time Fourier transform with 10 min epochs of HRV overlapping by 40%. The spectral power was divided into three segments according to high frequency, low frequency, and very low frequency bandwidths and averaged to fit quadratic regression models. The analysis of the mean R–R intervals showed significant differences between the groups (p = 0.029). The power variation over time was significant in each spectral band (p ≪ 0.05). The average power, maximum power, and time when the peak was reached differed for each band and between groups, showing the ability to correctly identify the decompensation of the ANS and discriminate between hypotensive and non-hypotensive patients. Additionally, the changes in the sympathovagal ratio were not significant and very scattered for the hypotensive group (p = 0.23) compared to the non-hypotensive group, where the changes were significant (p ≪ 0.05) and much less scattered.
No takes yet. Share an insight, caveat, or question.
Becerra‐Luna et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: